(+/-)-1-(1,2,3,4-tetrahydronaphth-1-yl)piperazine | 159671-87-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: (+/-)-1-(1,2,3,4-tetrahydronaphth-1-yl)piperazine
• 英文别名: 1-(1,2,3,4-tetrahydronaphthalen-1-yl)piperazine；1-(1,2,3,4-tetrahydronaphthyl)-1-piperazine；1-(1,2,3,4-tetrahydronaphthyl)piperazine
• CAS: 159671-87-1
• 化学式: C₁₄H₂₀N₂
• mdl: MFCD11901028
• 分子量: 216.326
• InChiKey: DLLBLNFCUXJHHV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  15.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (+/-)-1-(1,2,3,4-tetrahydronaphth-1-yl)piperazine 在 potassium carbonate 、 一水合肼 、 sodium iodide 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 24.0h， 生成 3-[4-(1,2,3,4-Tetrahydronaphthalen-1-yl)piperazin-1-yl]propan-1-amine
  参考文献：
  名称：

  New Benzocycloalkylpiperazines, Potent and Selective 5-HT_1A Receptor Ligands

  摘要：

  A series of 1-(benzocycloalkyl)-4-(benzamidoalkyl)piperazine derivatives was prepared in order to obtain compounds with a high affinity and selectivity for 5-HT1A receptors. The modifications of aromatic substituents, the length of the alkyl chain, and the size of the ring were explored. Most of N-(1,2,3,4-tetrahydronaphthyl)-N'-(benzamidoethyl)piperazines (32-37) were bound to 5-HT1A receptors in a nanomolar range and presented a high degree of selectivity. After resolution, levorotatory enantiomers showed affinity and selectivity higher than those of dextrorotatory ones for 5-HT1A sites. The agonist type activity of selected derivatives was also confirmed in vitro on the inhibition of the activation of adenylate cyclase induced by forskolin and, in vivo, on the induction of the lower lip retraction in rats.

  DOI：

  10.1021/jm950759z
• 作为产物：
  描述：

  1,2,3,4-四氢-1-萘酚 在 氢氧化钾 、 氯化亚砜 、 potassium carbonate 、 sodium iodide 作用下， 以 甲醇 、 水 、 甲苯 、 乙腈 为溶剂， 反应 25.0h， 生成 (+/-)-1-(1,2,3,4-tetrahydronaphth-1-yl)piperazine
  参考文献：
  名称：

  Synthesis of 1-[w-[(Arylamino)carbonyl]-alkyl]-4-(benzocycloalkyl)piperazines

  摘要：

  DOI：

  10.3987/com-97-7736

文献信息

• [EN] TETRAHYDRONAPHTHYL- PIPERAZINES AS 5-HT1B ANTAGONISTS, INVERSE AGONISTS AND PARTIAL AGONISTS<br/>[FR] TETRAHYDRONAPHTHYLPIPER- AZINES UTILISEES EN TANT QU'AGONISTES INVERSES, AGONISTES PARTIELS ET ANTAGONISTES DE 5-HT1B
  申请人：PFIZER PROD INC

  公开号：WO2005113527A1

  公开（公告）日：2005-12-01

  The present invention relates to novel tetrahydronaphthylpiperazines derivatives, that are compounds of the formula (I) wherein R1, R2 and R6 are as defined herein, X is CH2 or O, A is a group of the formula (G1, G2, G2a, G3, G4, G5 or G6) depicted below, and D is a group of the formula (D), wherein Y, W and Z are C or N and wherein R7 is as defined herein and their salts and compositions which include selective antagonists, inverse agonists and partial agonists of serotonin 1 (5-HT1) receptors. Compounds of the invention are useful in treating or preventing depression, anxiety, obsessive compulsive disorder (OCD) and other disorders for which a 5-HT1 agonist or antagonist is indicated.

  本发明涉及新型四氢萘哌嗪衍生物，即式(I)中R1、R2和R6如本文所定义，X为CH2或O，A为下图所示的式(G1、G2、G2a、G3、G4、G5或G6)的基团，D为式(D)的基团，其中Y、W和Z为C或N，R7如本文所定义，以及它们的盐和组合物，包括选择性5-羟色胺1(5-HT1)受体的拮抗剂、逆向激动剂和部分激动剂。本发明的化合物在治疗或预防抑郁症、焦虑症、强迫症(OCD)和其他需要5-HT1激动剂或拮抗剂的疾病中具有用途。
• Novel N-acylated heterocycles
  申请人：Recordati S.A.

  公开号：US20030162777A1

  公开（公告）日：2003-08-28

  Described are compositions comprising a muscarinic receptor antagonist and an N-acylated heterocycle derivative having affinity for serotonergic receptors, and enantiomers, diastereoisomers, N-oxides, polymorphs, solvates and pharmaceutically acceptable salts thereof. The combination of a muscarinic receptor antagonist and an N-acylated heterocycle, or an enantiomer, diastereoisomer, N-oxide, polymorph, solvate or pharmaceutically acceptable salt thereof, is useful in the treatment of patients with neuromuscular dysfunction of the lower urinary tract and diseases related to 5-HT 1A receptors.

  描述了包含一种肌氨酸受体拮抗剂和一种对5-HT 1A 受体具有亲和力的N-酰化杂环衍生物的组合物，以及它们的对映体、二对映体、N-氧化物、多型体、溶剂合物和药用可接受盐。肌氨酸受体拮抗剂和N-酰化杂环，或其对映体、二对映体、N-氧化物、多型体、溶剂合物或药用可接受盐的组合，在治疗患有下尿路神经肌肉功能障碍和与5-HT 1A 受体相关疾病的患者中是有用的。
• [EN] NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2, 3-DIOXYGENASE (IDO) INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS DE PIPERAZINE AMIDE SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE L'INDOLÉAMINE 2,3-DIOXYGÉNASE (IDO)
  申请人：MERCK SHARP & DOHME

  公开号：WO2020112581A1

  公开（公告）日：2020-06-04

  Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

  本文披露了一种化合物，其化学式为（I），可以作为IDO酶的抑制剂：（I）。本文还披露了这些化合物在潜在的治疗或预防IDO相关疾病或紊乱中的用途。本文还披露了包含这些化合物的组合物。此外，本文还披露了这些组合物在潜在的治疗或预防IDO相关疾病或紊乱中的用途。
• Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
  申请人：Biedermann Elfi

  公开号：US06903118B1

  公开（公告）日：2005-06-07

  The invention relates to new piperazinyl-substituted pyridylalkane, alkene, and alkine acid amides substituted with saturated or one or several-fold unsaturated hydrocarbon residue in the carboxylic acid group according to the general formula (I) as well as methods for the production of these compounds, medicaments containing these and their production as well as their therapeutic use, especially as cytostatic agents and immunosuppressive agents, for example in the treatment or prevention of various types of tumors and control of immune reactions such as autoimmune diseases.

  该发明涉及一种新的哌嗪基取代的吡啶烷、烯烃和炔烃酸酰胺，其在羧酸基团中取代有饱和或一种或多种不饱和的碳氢残基，其通式为(I)，以及制备这些化合物的方法，含有这些化合物的药物及其制备，以及它们的治疗用途，特别是作为细胞毒药物和免疫抑制剂，例如在治疗或预防各种类型的肿瘤和控制免疫反应如自身免疫疾病中的应用。
• A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT1A receptor ligands
  作者：Giuseppe Caliendo、Ferdinando Fiorino、Elisa Perissutti、Beatrice Severino、Daniela Scolaro、Stefania Gessi、Elena Cattabriga、Pier Andrea Borea、Vincenzo Santagada

  DOI：10.1016/s0928-0987(02)00045-3

  日期：2002.7

  A series of novel 1,2,3-4-benzoyltriazole and saccharine derivatives were designed and synthesized by microwave heating. They were evaluated on a battery of receptors, including serotonin 5-HT(1A,) 5-HT(2A) and 5-HT(2C), and the most interesting compounds were further evaluated on dopaminergic D(1), D(2) and adrenergic alpha(1), alpha(2) receptors. Conventional and microwave heating of the reactions

  通过微波加热设计合成了一系列新颖的1,2,3-4-苯甲酰基三唑和糖精衍生物。在一系列受体上对它们进行了评估，包括5-羟色胺5-HT（1A），5-HT（2A）和5-HT（2C），并在多巴胺能D（1），D（2）上进一步评估了最有趣的化合物。 ）和肾上腺素的alpha（1），alpha（2）受体。比较了反应的常规加热和微波加热。通过微波加热的合成比通过常规加热获得的所需化合物具有更好的产率。合成的总时间大大减少了。所有化合物显示出对5-HT（1A）受体的中等亲和力。最有趣的化合物33显示出高亲和力（K（i）＝ 93nM），其与对所考虑的其他受体没有亲和力结合。